Related Experiment Video
Updated: Mar 9, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
[Fatal interstitial lung disease associated with maximum androgen blockade]
Guillermo Molina Mancero1, Xavier Picón1, Fernando Di Tullio2
1Unidad de Cuidados Intensivos, Hospital Británico de Buenos Aires, Argentina.
Maximum androgen blockade for prostate cancer can cause interstitial lung disease. A patient with advanced prostate cancer developed severe respiratory failure and died, with pathology confirming Usual Interstitial Pneumonia.
Area of Science:
- Pulmonology
- Oncology
- Pathology
Background:
- Maximum androgen blockade is a standard treatment for advanced prostate cancer.
- Interstitial lung disease (ILD) is a potential side effect of this treatment, varying in severity.
- ILD associated with maximum androgen blockade typically has low mortality and responds well to treatment.
More Related Videos
07:10Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
Published on: May 20, 2019
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation